The maintenance of sinus rhythm is crucial for the functional capacity of patients with hypertrophic cardiomyopathy (HCM). Using a multimodality approach, we attempted to identify potential predictors of paroxysmal atrial fibrillation (PAF) in HCM patients.
Introduction
Atrial fibrillation (AF) is the most common sustained arrhythmia in patients with hypertrophic cardiomyopathy (HCM) 1 ; it has an annual incidence of roughly 2%, four to six times more frequent compared with the general population, and is expected to occur at least once in 25% of the HCM patients in the course of their lives. 2, 3 Whereas chronic AF is associated with higher rates of adverse clinical events, paroxysmal AF (PAF) can also be detrimental. The loss of contractile function of the left atrium (LA) in the presence of already impaired ventricular diastolic filling can result in acute clinical decompensation and syncope 4 ; moreover, stroke risk is independent from the duration or the number of documented arrhythmic episodes. 3 LA size has long been identified as an AF predictor 5 ; not unexpectedly, AF risk stratification in HCM was focused on LA size and function. 6 -8 Routine non-invasive evaluation of LA mechanical function has been based on echocardiography using diameterand volume-derived indices, 9,10 whereas its electrophysiological properties were explored mainly with the signal-averaged electrocardiogram (ECG) 11, 12 ; however, new research tools are available nowadays. Deformation properties of the LA myocardium have been studied and identified as predictors of maintenance of sinus rhythm in patients with lone AF. 13 On the other hand, wavelet transform analysis of the P-wave has been found by our group to provide new AF predictors in patients without overt structural heart disease 14 and in those undergoing coronary artery bypass surgery. 15 This study assessed the possible incremental value of LA deformation properties and P-wave wavelet analysis for the risk stratification for PAF in a HCM patients' population.
Methods

Study population
This was a retrospective, single-centre, case -control study. Patients with familial HCM, who all had at least one documented PAF episode, were asked to participate in the study together with sexand age-matched arrhythmia-free control HCM patients. The diagnosis of HCM was based on left ventricular (LV) maximum wall thickness ≥15 mm on echocardiography, in the absence of other cardiac or systemic disorders capable of producing a similar degree of hypertrophy; HCM was also diagnosed in patients with maximum wall thickness values of 13 or 14 mm in the presence of a positive familial history for HCM and/or ECG changes compatible with HCM. 16 Patients with either chronic AF, history of cardiac surgery, frequent supraventricular ectopy (.1% of cycles on Holter ECG) or dependence on the pacemaker function of an implantable cardioverter-defibrillator were excluded from the study. Out of the eligible 37 HCM-PAF patients, 7 were excluded; in the end, we enrolled 30 HCM-PAF patients (17 males, mean age 57.9 + 13.6) and 32 HCM control patients. All of the patients were in sinus rhythm when studied; acquisition of data was performed no sooner than 2 weeks after conversion to sinus rhythm in order to minimize the potential effect of stunning and immediate post-conversion electrical instability on our results. 17 Twenty-five healthy sex-and agematched volunteers were studied as well. They were all free of cardiovascular disease; none of them had abnormal findings on physical examination, ECG, or conventional echocardiographic examination. The study complies with the Declaration of Helsinki regarding investigation in humans and was approved in advance by the institutional Medical Ethics Committee; written informed consent was obtained from each participant before enrolment.
Echocardiography
Echocardiographic studies were performed using a commercially available Vivid 7 scanner (GE Medical Systems, Horten, Norway). Standard parasternal and apical views were recorded in a 2D grey-scale mode; apical four-chamber views including zoomed views of the atria were also recorded in a colour Doppler myocardial imaging (CDMI) mode. Three consecutive complete cardiac cycles were recorded in a cineloop format and stored on magneto-optical discs for off-line analysis.
Standard two-dimensional echocardiography
Measurements and tracings were performed following the international standards 18 and previously published reports on HCM. 19, 20 The LV ejection fraction was calculated with the modified Simpson's rule; obstruction of the LV outflow tract was considered to be present, when a peak instantaneous outflow gradient was estimated to be at least 30 mmHg under resting conditions. The antero-posterior LA diameter (LAD AP ) and the maximal LA volume (LAV max ) were measured in the end-systole; both variables were also indexed to body surface area. The biplane area-length method was used for LA volume measurements; special attention was paid to start/end tracing at the mitral annulus treating the annulus plane as the inferior LA border and to exclude the ostia of the pulmonary veins and the LA appendage from the tracing.
18,21
Left atrial colour Doppler myocardial imaging study
Data were acquired in zoomed LA views; data were triggered to the QRS complex and analysed off-line by commercial software (Echopac, GE Medical Systems). The colour myocardial velocity range setting was optimized to avoid aliasing within the image. The narrowest possible sector angle (≤308) was selected in order to achieve the highest frame rate possible (a minimum of 100 frames/s). The recorded atrial wall was always positioned in the centre of the sector and re-aligned so that the direction of motion studied was as near as possible parallel to the direction of the insonating beam. 13, 22, 23 Peak longitudinal strain rate (SR) and corresponding strain (1) values were measured in mid/high-wall segments at the LA septal and lateral wall during the phases of LA function. The LA contractile phase (A) was defined as the interval between the onset of the P-wave and the mitral valve closure, the LA reservoir phase (S) was defined as the interval between mitral valve closure and mitral valve opening, and the LA conduit phase (E) as the interval between mitral valve opening and the onset of the P-wave. Regional lengthening as observed during the reservoir phase was expressed as a positive value, whereas regional shortening as a negative value, as observed during the conduit and the contractile phase.
To derive 1/SR profiles from the studied segment, a region of interest of 9*2 with an elliptical shape was used; care was taken that it was continuously positioned within the segment interrogated, avoiding the membranous septum (measurements performed corresponding to the muscular structure at the rim of the oval fossa), the pulmonary veins' ostia and the LA appendage. In order to reduce noise, 1/SR measurements were analysed and averaged over three consecutive cardiac cycles. 13, 22, 23 Intra-and inter-observer variability was assessed for LAD AP , LAV max , and 1/SR variables calculated in the lateral LA wall. Ten data sets were randomly selected and analysed. To determine intra-observer variability, analysis was repeated twice by the same observer within 4 weeks; for inter-observer variability, analysis was performed by a second independent observer.
P-wave analysis
Orthogonal ECG recordings employing three bipolar orthogonal leads (X, Y, and Z) were obtained from all study subjects with the application of a three-channel digital recorder (Galix Biomedical Instrumentation, Inc., USA). 15 Recordings were performed for 10 min in a noise-free environment with the subjects lying in the supine position. The ECGs were digitized with a sampling frequency of 1000 Hz. Thirty consecutive P-waves were selected from each subject's ECG and preprocessed with amplitude normalization, baseline correction, and application of a denoising wavelet filter. 24 In order to measure the P-wave duration, its start and end were manually identified on the orthogonal ECG in each cardiac cycle using a cursor on a high-resolution computer screen.
Continuous wavelet transform using the Morlet mother wavelet 14 was applied for P-wave analysis in the X, Y, and Z orthogonal leads, as well as in the composite vector axis using customized software . Analysis was performed separately for each orthogonal lead as well as for the composite vector axis, thus resulting in 24 P-wave energy variables being calculated for each study subject. The terminology that was used in our study to describe these energy variables was {Mean/Max}{frequency band}{orthogonal lead}, e.g. Max3Z corresponded to the maximum energy of the P-wave in the low frequency band in the Z-orthogonal lead ( Figure 1 ). when not, as median (25-75th percentile) . Comparisons between the three subgroups of our population were performed with one-way analysis of variance (ANOVA) for normally distributed variables; the Bonferroni post hoc analysis was applied between the two patient groups. The Kruskal-Wallis test was applied for non-parametric comparison between independent samples. Pearson's correlation coefficient was used to measure the strength of association between selected variables. In order to determine intra-and inter-observer variability, we performed the Bland -Altman analysis. The mean of signed paired differences (bias) and its SD were calculated; the 95% limits of agreement were determined and reported both as an absolute value and as a percentage of the observer(s) average value.
Potentially independent factors discriminating HCM-PAF patients were identified by univariable logistic regression analysis and were then entered into multivariable analysis; given the number of events (30), a maximum of three variables were entered at a time. Multiple models were compared in terms of calibration, discrimination, and the percentage of data variability explained by a given model (Nagelkerke's R 2 ); the optimal model was then determined. Calibration was explored with the Hosmer -Lemeshow goodness-of-fit test; discrimination was explored with the areas under the receiver-operating characteristics (ROC) curves. Adverse event (PAF) probabilities calculated by a given multivariable model were saved and plotted by means of an ROC curve to derive its discriminatory ability. Areas under the curves (AUCs) were compared between models and/or individual variables with the DeLong method 25 using MedCalc for Windows, version 11.6.0.0 (MedCalc Software, Mariakerke, Belgium). For the variables included in the optimal multivariable model, cut-off values were identified; sensitivity and specificity were also determined. All statistical tests were two-sided and a value of P , 0.05 was considered statistically significant. vector axis of a given recording/patient. In this graph, P-wave duration is shown at X-axis, frequency at Z-axis, and P-wave energy at Y-axis; values for P-wave duration and energy parameters, as defined in text, are also reported. The red asterisk denotes the maximum energy of P-wave, which occurred at the third (low) frequency band (50 -90 Hz). This analysis was derived from a patient with documented episodes of paroxysmal atrial fibrillation.
Results
There was no significant difference in age or gender across all three groups of study subjects, confirming good age and sex matching. Among the HCM-PAF patients, 10 had experienced only one documented PAF episode, whereas 20 patients had one or more recurrences. On average, each patient had 2.7 + 2.1 documented episodes; 20 patients had ≤3 episodes and 10 patients had .3, up to a maximum of 10 episodes. Demographics, symptom status, and risk factors are presented in Table 1 . Control patients did not significantly differ from HCM-PAF patients in NYHA status (P ¼ 0.14). There was no difference in terms of antiarrhythmic medication (including b-blockers) between the two HCM patient groups, except for amiodarone (P ¼ 0.001). Nevertheless, there was no difference in average heart rate among all three study groups (P ¼ 0.89).
Two-dimensional echocardiography
Selected LV and LA parameters are presented in Table 2 . There was no significant difference in LV ejection fraction (P ¼ 0.74) or filling pattern (E/A, P ¼ 0.11 and E-wave deceleration time, P ¼ 1.00) between the two patient groups. Antero-posterior LA diameter, both in absolute measure and indexed to body surface area, was significantly increased in HCM-PAF compared with the control patients (P , 0.001 for both parameters). Maximal LA volume, absolute or indexed, was also increased; however, difference failed to reach statistical significance (P ¼ 0.07 and 0.09, respectively).
Left atrial colour Doppler myocardial imaging study
Recordings were performed at an average of 137 (100-216) frames/s; 1/SR values for all three phases of LA function are presented in Table 3 . Values for the lateral wall were significantly larger compared with the septum (P , 0.01 for every comparison). Lateral wall peak SR values during the reservoir phase (LAT peak SR-S) were significantly decreased in HCM-PAF compared with control patients (P , 0.01). In HCM patients, there was a weak inverse correlation between LA size and SR measures at the lateral LA wall (LAV max vs. LAT peak SR-S, r ¼ 20.24, P ¼ 0.06; LAD AP vs. LAT peak SR-S, r ¼ 20.30, P ¼ 0.02). Variability estimates for echocardiographic measurements are shown in Table 4 .
P-wave analysis
Values for P-wave duration as well as for all 24 energy variables derived from the orthogonal ECG analysis are presented in Table 5 . P-wave duration was consistently and significantly prolonged in the HCM-PAF compared with the control patients (P , 0.001 for every orthogonal lead and the composite vector axis); P-wave duration in Z-lead (P-durZ) had a significant albeit weak correlation with LAD AP (r ¼ 0. Mean1VM and Mean2VM values in HCM-PAF compared with control patients; however, this difference was significant only for Mean3VM (P ¼ 0.02). Parameters that showed significant differences between the two HCM patient groups were adjusted for amiodarone administration (0/1) to cancel out its plausible effect on P-wave analysis. P-wave duration in X, Y, and Z leads identified PAF patients independently from amiodarone (P ≤ 0.01 for all); however, this was not the case for any of the energy variables.
Multivariable analysis
All individual variables that identified HCM-PAF patients in univariable analysis at a level of significance P , 0.10 are shown in Table 6 ; AUC values are also reported. After constructing multiple models, analysis resulted in one model combining LAD AP , LAT peak SR-S, and P-durZ ( Table 7) , and 98.8 ms; sensitivity -specificity were 0.80-0.75, 0.87-0.66, and 0.60-0.88, respectively. Comparing AUC between these variables, none was clearly superior (P . 0.40 for all comparisons), whereas the final model had a higher AUC compared with LAT peak SR-S (P , 0.01), P-durZ (P ¼ 0.03), and LAD AP (P ¼ 0.06). Administration of amiodarone (0/1) could still be fitted into this model ( Table 7) ; since it was not deemed a real discriminator of PAF, but rather a post hoc medical decision, it was left out of the final model. 
Discussion
Our study has demonstrated that by combining wavelet analysis of the P-wave with LA echocardiographic evaluation including 1/SR measurements, we identified HCM-PAF patients with greater sensitivity and specificity. To our knowledge, this is the first study where these modalities were applied together to any subject population. P-wave prolongation along the Z-lead of the orthogonal ECG coupled with LAD AP enlargement and decreased LAT peak SR-S expressed multiple aspects of the electrical and structural LA remodelling that has been described to promote and perpetuate AF episodes.
17,26
Left atrial size LAD AP has been used for years as a measure of LA size 5 ; moreover, in a large community-based HCM population, LAD AP .45 mm was the strongest independent predictor of either paroxysmal or chronic AF. 3 However, compared with LAD AP , LAV max has been shown to have higher accuracy in quantifying the real LA size, and thereby a higher power to identify patients with AF episodes. 27 -29 In our study, we found larger LAV max values (absolute and indexed) in HCM-PAF compared with HCM control patients, very similar to findings reported in other HCM patient cohorts. 6, 7, 30 However, in our study, there was no significant difference between the two patient groups, probably attributable to a type II error due to our limited sample size. Unexpectedly, it was the LAD AP that discriminated the two groups with higher sensitivity and specificity. Being anatomically constrained between the spine and the sternum, 27 LA would not be expected to preferentially grow in this direction. Nevertheless, in already severely enlarged atria, it may be that excessive LA enlargement in this direction makes a difference between the two groups, as demonstrated previously. 6 
Left atrial function
LA enlargement is an adaptation to longstanding high diastolic LV pressures in an attempt to maintain LV filling. 29 However, this comes at the cost of interstitial fibrosis, abnormal myocyte relaxation, reduced contractility, and increased vulnerability for arrhythmic episodes. 17, 21, 26 The association between decreased LA function and AF has been established via both diameter-and areaderived indices 6,31 as well as via LA deformation properties. 13, 32, 33 Patients in these latter studies were free of structural heart disease exhibiting on average only mild diastolic dysfunction. However, in HCM patients, LA function during both reservoir and contractile phases is reported to be reduced earlier in the disease course and to a greater extent compared with other forms of LV hypertrophy. 23 Both HCM patient groups in our study represented a mixture of patients with evolving diastolic dysfunction; by the premise that on the long-term this is reflected by LA size, HCM-PAF patients fared on average worse in that aspect. Diminished LA compliance in these patients translated into worsening peak SR values during the reservoir phase. Nevertheless, whereas strain values are dependent on loading conditions, 13 there was only a weak correlation between peak SR values and LA size; it is plausible that the rate of deformation reflects an intrinsic atrial myopathy in the context of the disease process itself and thereby holds an added predictive value for AF development independent of LA enlargement. One might expect that this myopathy would have been reflected by a more pronounced decline in the absolute 1/SR values during the contractile phase. However, according to findings from studies including patients with structural heart disease and reported PAF episodes, 32, 33 reservoir phase were recently shown to be the best individual predictors of sinus rhythm maintenance after catheter ablation for AF. 34 An enlarged, stiffened, and fibrotic atrium is highly likely to create local intra-and inter-atrial conduction delays and thereby set the scene for micro-and macro-reentry; it follows that the decline in peak SR-S and the prolongation of P-durZ in our study may reflect different aspects of the same pathophysiological process.
P-wave analysis
The potential of P-wave analysis to predict AF episodes has extensively been explored in diverse patient groups via the signal-averaged ECG, focusing on a prolonged P-wave duration 8, 11, 12 as well as the energy and frequency content of its terminal portion. 12 The suggested added value of the wavelet analysis compared with conventional time-or frequency domain techniques lies in the ability to unveil dynamic changes and detect small signal components in large constituent waves during the whole heart cycle. Applying this novel analysis method, energy parameters along the Z-lead have indicated a different activation pattern in patients developing AF after coronary artery bypass surgery, 15 whereas larger Max1X values could predict increased AF recurrences in patients without overt structural heart disease. 14 Interestingly, in both studies, it was the Z-lead where prolongation of the P-wave was more pronounced in AF patients. In a population as diverse in LA size and function as ours, P-wave duration along the Z-lead was again identified as a variable that could discriminate the PAF patients with high sensitivity and specificity. Excessive LA growth could set the scene for local conduction delays through enhanced non-uniform anisotropy. Nevertheless, being independent from LA size in multivariable analysis, P-wave prolongation in the Z-lead could also imply a deviation of inter-atrial conduction from its preferred route. Regarding the energy parameters, mean energy values along the composite vector axis showed increased values in the HCM-PAF patients; however, no parameter was significantly associated with PAF in univariable analysis. Admittedly, a prospective, appropriately sized study would be needed to verify whether local maxima and uncovered non-stationarities in the P-wave would have the potential to discriminate AF prone patients in such a challenging population.
Limitations
This study is limited by its retrospective design and the relatively small sample size; due to the low annual incidence of AF, a prospective analysis was not included in our study. However, all eligible patients from our database were studied and a careful matching process was performed thereby limiting the selection bias as much as possible. There was heterogeneity in the PAF group regarding the time elapsed from the last arrhythmic episode, duration, and frequency of episodes; the relatively small sample size did not permit a breakdown of our HCM-PAF population into subgroups of more or less arrhythmic load for fear of a type II statistical error.
Amiodarone may admittedly have affected the P-wave duration and the energy parameters calculated; however, for ethical and practical reasons, it could not have been discontinued. Nevertheless, it has been reported that amiodarone could actually shorten the P-wave duration, 35 which is the opposite effect of what was shown in the HCM-PAF patient group. Moreover, parameters derived from the Morlet wavelet analysis have been adjusted for amiodarone administration, wherein some energy variables were ruled out as potential discriminators of AF. Amiodarone administration could be fitted to the optimal multivariable model thereby also adjusting for possible effect on the SR component. The higher predictive value of the 1/SR measurements in the reservoir phase could partly be attributed to higher repeatability. It was easier to identify the peak systolic strain on the derived curve; SR signals, possibly by virtue of comparatively larger values, had also higher repeatability. Strain and SR were not Figure 2 Receiver-operating characteristic curves for variables significant in multivariable analysis (left panel) and for the final model made up of these variables (right panel). Left atrium (LA) antero-posterior diameter (LAD AP ), lateral LA wall peak strain rate in the reservoir period (LAT peak SR-S), and P-wave duration on the Z-orthogonal lead (P-durZ) when combined result in a model with a higher area under the curve for discriminating patients with paroxysmal atrial fibrillation.
calculated on the two-chamber view; however, the lateral LA wall has been reported to provide higher values compared with the anterior and inferior wall in healthy subjects. 22 Thus, reported values
give a reasonable account of LA deformation properties and are in accordance with published studies. Finally, aside from 1/SR values, there are a number of added variables that can be extracted from LA CDMI analysis which could be linked to AF development. Measurements of regional atrial contraction velocities can identify local differences in motion and help follow the extent of mechanical remodelling over time. 36 However, as opposed to 1/SR computations, velocity measurements are not independent from the tethering effect and global cardiac motion, hence the higher sensitivity and specificity of deformation properties. 13 On the other hand, high ECG temporal resolution of modern ultrasound machines permits the accurate study of the electrical activation sequence of the atrial myocardium; studied parameters include the time interval between the beginning of the ECG P-wave and the onset of atrial systole, the time to peak 1/SR values during the contractile phase, or the entire duration of atrial electromechanical activity of individual LA segments. 22, 37 Exaggerated differences in respective variables between LA segments and/or the right atrium free wall reflect intra-and/or inter-atrial conduction delay, which may promote and perpetuate an AF episode initially triggered by atrial ectopic activity. 33, 38 Despite several significant differences identified in univariable analysis, none of these parameters (segmental contraction velocities and/or time intervals) also studied in our population made it to the final multivariable model; in the interest of clarity and limited by the extent of a single manuscript, we chose not to present the respective results here.
Conclusions
A systematic multimodality approach combining wavelet analysis software and advanced echocardiographic imaging provided us with a model, which correctly identified HCM patients with documented episodes of PAF among their arrhythmia-free counterparts. Increased LA antero-posterior diameter, coupled with prolonged P-wave duration on the Z-lead of the orthogonal ECG, and diminished deformability of the LA lateral wall in the reservoir phase address different electromechanical properties, which could be underlying PAF generation. Nevertheless, the relatively small sample size of our study together with potential confounders, such as antiarrhythmic medication, call for the crossvalidation of our model in a larger prospective study.
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